Ganga Pharmaceuticals Limited concluded its 37th Annual General Meeting (AGM) on September 26, 2026, at its registered office in Virar, Maharashtra. The meeting, which commenced at 4:30 pm and ended at 4:55 pm, saw the unanimous adoption of financial statements and the approval of all agenda items by the members present.

The proceedings were conducted in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Sanjay Kulkarni, Chairman of the Board, presided over the meeting and welcomed the members. He briefed the attendees on the company's performance during the previous fiscal year and outlined plans for the current year.

Attendance and Quorum

A total of 10 members were personally present at the meeting. After verifying that the requisite quorum was met, the Chairman called the meeting to order. The Register of Directors' Shareholding was kept open for inspection throughout the duration of the AGM.

Directors Present

Other key personnel present included Mr. Gaurav Thakur, representative of M/s. Gaurav Thakur & Co (Scrutinizer), Mr. Pradeep Banka from Banka & Bank (Statutory Auditors), Mr. Dhirendra Maurya from M/s. D Maurya & Associates (Secretarial Auditor), and Mr. Anagh Sharma, Chief Financial Officer.

Voting Process and Resolutions

In accordance with Section 108 of the Companies Act, 2013, the company offered a remote e-voting facility to enable members to cast their votes electronically. The remote voting window opened on September 23, 2026, at 9:00 am and closed on September 25, 2026, at 5:00 pm.

During the physical meeting, the Chairman invited members to raise any queries or comments regarding the agenda items. Following this, Mr. Gaurav Thakur was introduced as the Scrutinizer for the voting process. A poll was ordered for all ordinary and special business items listed in the AGM notice. The final poll results, including e-voting outcomes, were announced to be displayed on the company's website upon receipt of the report from the Scrutinizer.

The meeting concluded without any qualifications noted in the Audit report, as the financial statements, Board's Report, and Auditor's Report were taken as read with unanimous consent.

Ganga Pharmaceuticals Limited has scheduled its 37th Annual General Meeting (AGM) for Saturday, September 26, 2026. The meeting will convene at 4:30 pm at the company’s registered office in Virar East, Palghar.

The Board of Directors notified BSE Limited on September 1, 2026, regarding the convening of the AGM and the release of the Integrated Annual Report for FY26. The notice was signed by Bharat Sharma, Managing Director. In compliance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company issued letters to shareholders without registered email addresses, providing web links to access the AGM notice and annual report on the company website and the BSE exchange portal.

Key Agenda Items

The AGM will transact both ordinary and special business. Shareholders will consider the adoption of the audited financial statements for the year ended March 31, 2026. Additionally, Mr. Sanjay Kulkarni (DIN: 00065190), Non-Executive Chairman, retires by rotation and offers himself for re-appointment.

A special resolution seeks shareholder approval for the re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director & CEO for a three-year term from April 1, 2026, to March 31, 2029. His remuneration is capped at ₹21.6 lakh per annum.

Financial Performance FY26

The explanatory statement accompanying the notice discloses key financial metrics for FY26 compared to FY25. Total income rose slightly to ₹310.70 crore from ₹307.33 crore. Profit after tax expanded to ₹10.15 crore from ₹7.90 crore.

Voting and Book Closure Details

Shareholders must adhere to specific dates to exercise their voting rights. The cut-off date for determining eligibility to vote is Friday, September 18, 2026.

The company will utilize the remote e-voting system of Central Depository Services Limited (CDSL). The e-voting window opens on Wednesday, September 23, 2026, at 9:00 am and closes on Friday, September 25, 2026, at 5:00 pm.

Shareholders are urged to register their email IDs with their Depository Participants or the company’s RTA to receive future financial reports and corporate benefits electronically.

Regulatory Compliance

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will remain closed from Sunday, September 20, 2026, through Saturday, September 26, 2026. This closure applies to equity shares for the purpose of the AGM.

The Annual Report and AGM Notice are available on the company website, www.ayurvedganga.com , in compliance with Regulation 34(1) of the SEBI LODR Regulations, 2015.